M4MM
Aegis Capital Maintains Buy Rating on atai Life Sciences with $8 Target
LOS ANGELES- Aegis Capital has reaffirmed its Buy rating on atai Life Sciences N.V. (NASDAQ: ATAI), maintaining a price target of $8 following the release of positive Phase 2b results for BPL-003, the company’s investigational ...
ICE Raids California Cannabis Farms as Budget Swells and Allegations Mount
CARPINTERIA, Calif. — In a sweeping operation that has stirred legal, political, and cultural tensions across California, federal immigration authorities executed high-profile raids on two cannabis farms operated by Glass House Brands, one of the ...
Legal Status of Cannabis in Europe
LOS ANGELES- A growing number of European countries now permit the use, cultivation or sale of cannabis under regulated conditions, driven by evolving public policy and emerging economic opportunity. Germany legalized limited recreational use on ...
Texas Senate Passes Bill to Ban Hemp THC
DALLAS–The Texas Senate has taken a major step toward banning consumable hemp products that contain THC or other intoxicating cannabinoids, a move that could severely impact an $8 billion industry employing approximately 50,000 workers. On ...
Planet 13 Schedules Release of Q4 2024 Financial Results
LOS ANGELES- Planet 13 Holdings Inc. a vertically integrated multi-state cannabis company, has announced that it will release its financial results for the fourth quarter and full year ending December 31, 2024, on March 26, ...
POSaBIT Captures Majority of Cannabis Transactions in Washington State
LOS ANGELES- POSaBIT Systems Corporation a provider of point-of-sale and payments infrastructure in the cannabis industry, now processes over 85% of all cannabis point-of-sale transactions in Washington State. Established in 2015, POSaBIT has expanded ...
Hemp-Derived Products Influence Cannabis Market Dynamics
LOS ANGELES- The 2018 Farm Bill's legalization of hemp cultivation has significantly impacted the cannabis industry, leading to the emergence of various hemp-derived products that are reshaping market dynamics. One notable development is the ...
Aegis Capital Maintains Buy Rating on atai Life Sciences with $8 Target
LOS ANGELES- Aegis Capital has reaffirmed its Buy rating on atai Life Sciences N.V. (NASDAQ: ATAI), maintaining a price target of $8 following the release of positive Phase 2b results for BPL-003, the company’s investigational ...
ICE Raids California Cannabis Farms as Budget Swells and Allegations Mount
CARPINTERIA, Calif. — In a sweeping operation that has stirred legal, political, and cultural tensions across California, federal immigration authorities executed high-profile raids on two cannabis farms operated by Glass House Brands, one of the ...
Legal Status of Cannabis in Europe
LOS ANGELES- A growing number of European countries now permit the use, cultivation or sale of cannabis under regulated conditions, driven by evolving public policy and emerging economic opportunity. Germany legalized limited recreational use on ...
